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OBJECTIVES The purpose of this investigation was to differentiate chronic pulmonary thromboembolism
(CPTE) from primary pulmonary hypertension (PPH) by means of the indexes of pulmonary
arterial reflection.
BACKGROUND These differences in the primary lesions would make pulmonary artery reflection occur earlier
in CPTE than in PPH. Although the analysis of pulsatility of pulmonary arterial pressure is
useful in the differential diagnosis of PPH and CPTE, it is not known whether the analysis
of pulmonary artery reflection can differentiate CPTE from PPH.
METHODS Since CPTE predominantly involves the proximal arteries, whereas PPH involve the
peripheral arteries, we hypothesized that patients with CPTE have a large augmentation
index and a short inflection time. For this study, we enrolled 62 patients who had CPTE (31
patients) and PPH (31 patients). We measured pulmonary arterial pressure using a fluid filled
system that included a balloon-tipped flow directed catheter. To quantify the pulmonary
artery reflection, we used the augmentation index and inflection time.
RESULTS The augmentation index was markedly higher in CPTE than it was in PPH (27.4% 6 15.2%
[SD] and 225.1% 6 26.9%, respectively, p , 0.001) and was diagnostic in separating the two
groups. Inflection time separated the two groups reasonably well (97 6 20 ms and 210 6
49 ms, respectively, p , 0.001).
CONCLUSIONS The analysis of pulmonary arterial reflection is useful in the differential diagnosis of CPTE
and PPH. (J Am Coll Cardiol 2001;38:214–8) © 2001 by the American College of
Cardiology
The augmentation index (i.e., the magnitude of the second-
ary rise in pressure relative to pulse pressure) and the
inflection time (i.e., the period from the onset of the
pressure increase after diastole to the inflection point) give
information on the magnitude and return time of reflected
waves, respectively (1–3). The distance of the reflection site
and the pulse wave velocity then determines the inflection
time. When the reflection is large, such as when an embolus
is present, the augmentation index will be large, and the
inflection time is determined by the location of the embolus.
Differential diagnosis between chronic pulmonary throm-
boembolism (CPTE) and primary pulmonary hypertension
(PPH) remains a clinical challenge. In particular, the correct
diagnosis of CPTE is a prerequisite for life-saving surgical
procedures (4). Chronic pulmonary thromboembolism pre-
dominantly involves the proximal arteries, that are usually
stiff (i.e., have a pulse wave velocity), whereas in PPH the
periphery is involved with relatively compliant arteries.
Therefore, we hypothesized that pulmonary artery (PA)
reflections would return with greater magnitude, producing
an increased augmentation index and with shorter inflection
time. The results of our study, indeed, indicate that this is
the case and that this information can be used in differen-
tiating CPTE and PPH.
METHODS
Study subjects. The study group consisted of 62 consecu-
tive patients who were admitted to the National Cardiovas-
cular Center, Osaka, Japan, because of symptomatic pulmo-
nary hypertension (New York Heart Association class II to
IV) between January 1997 and May 2000 and who were
subsequently diagnosed as having CPTE or PPH. Chronic
pulmonary thromboembolism was diagnosed when throm-
boembolism was positively diagnosed by means of both
pulmonary angiography and radioisotope ventilation-
perfusion imaging in patients with a clinical history com-
patible with CPTE. Primary pulmonary hypertension was a
diagnosis of exclusion made when other possible etiologies
of pulmonary hypertension (i.e., secondary causes), such as
mitral valve diseases, congenital heart disease, left ventric-
ular failure and CPTE were excluded. We excluded patients
with signs of collagen vascular disease from the PPH group,
positive antinuclear antibody, history of drug abuse, use of
diet pills or history of liver disease. The protocol was in
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accordance with Institutional Guidelines for Human Re-
search, and each individual provided a written statement of
informed consent for diagnostic and therapeutic procedures
required for examination, which stated that the results of the
examination could be used for the study.
Measurement of hemodynamic variables. We obtained
hemodynamic variables in the supine position. Pulmonary
arterial pressure was measured at end-expiration during a
short episode of breath-holding using a fluid-filled system
that included a balloon-tipped flow directed catheter (7F
Swan-Ganz catheter) in the main PA. A hard copy was
made of the pressure tracing using a chart recorder (Nihon
Koden, Surgical Monitoring System, Tokyo, Japan) at a
paper speed of 100 mm/s. We determined cardiac output
using the Fick principle based on oximetry.
We compared tracings of systolic, diastolic, mean and
pulse pressures in patients with CPTE and PPH. Pulmo-
nary pressure at inflection point dividing into an early and
late systolic phase was used as inflection pressure (1–3). The
inflection point in the pulmonary pressure divides systole in
an early and late phase (Fig. 1). We divided the PA pressure
waveform into three subgroups (A, B and C), according to
classification by Murgo et al. (1–3). The augmentation
index was defined as the ratio of inflection pressure to pulse
pressure in subgroup A and B, and as the ratio of minus
inflection pressure to pulse pressure in subgroup C. We used
inflection time (Dtp) as the time interval between onset of
systolic pressure waveform and inflection point (1–3).
Statistical analysis. Values are expressed as mean 6 one
SD. Differences in the mean values between the two groups
were compared by unpaired t test. Categorical variables were
compared using the chi-squared test. A p value of ,0.05
was considered significant.
RESULTS
Baseline clinical characteristics. The baseline clinical
characteristics of the study group are summarized in Table
1. There were 31 patients with CPTE (13 men and 18
women) whose average age was 39.4 6 12.6 years (range: 26
to 67 years). The rest of the patients had PPH (13 men and
18 women). Their average age was 49.8 6 11.1 years (range:
19 to 63 years). Medical therapy for pulmonary hyperten-
sion included loop diuretics (n 5 38), digoxin (n 5 33),
warfarin (n 5 29), calcium channel antagonists (n 5 9) and
beraprost sodium (oral prostaglandin I2 derivative) (n 5 28).
Four of the 31 patients with CPTE and five of the 31 with
PPH were taking calcium channel antagonists (p 5 NS).
Thirteen of those with CPTE and 15 with PPH were
taking beraprost sodium (p 5 NS). Although the distribu-
tion of gender, cardiac output and mean blood pressure were
similar, there were significant differences in the mean age
and heart rate.
Pulmonary hemodynamic variables. The pulmonary he-
modynamic variables characteristic of the study group are
summarized in Table 2. Systolic, diastolic and mean pres-
sures and total pulmonary resistance in the PA were higher
in patients with PPH than in patients with CPTE. There
were significant differences in augmentation indexes and
inflection time between the two groups.
Figure 1 illustrates the waveforms of PA pressure in the
case of CPTE (right panel) and in PPH (left panel). Although
heart rates are similar in the two cases, inflection point occurs
much earlier in CPTE than in PPH. As a result, inflection
time is, by far, shorter in CPTE than in PPH.
Abbreviations and Acronyms
CPTE 5 chronic pulmonary thromboembolism
PA 5 pulmonary artery
PPH 5 primary pulmonary hypertension
Figure 1. Pulmonary arterial pressure tracings in representative cases. The
left panel is from a patient with primary pulmonary hypertension (PPH).
The right panel is from a patient with chronic pulmonary thromboembo-
lism (CPTE). Inflection time is by far larger in PPH than it is in CPTE.
Inflection time, inflection point and inflection pressure are indicated.
Table 1. Baseline Characteristics of Patients
Variables PPH CPTE
p
Value
Men/number 13/31 13/31 1.00
Age (yr) 39.4 6 12.6 49.8 6 11.1 0.001
Heart rate (beats/min) 83.4 6 12.1 73.9 6 11.1 0.002
Cardiac output (l/min) 3.2 6 1.2 3.4 6 1.0 0.501
Mean blood pressure (mm Hg) 82.0 6 11.5 87.0 6 8.2 0.057
CPTE 5 chronic pulmonary thromboembolism; PPH 5 primary pulmonary hyper-
tension.
Table 2. Pulmonary Hemodynamic Variables
Variables PPH CPTE p Value
Systolic pressure (mm Hg) 97.2 6 16.6 77.1 6 14.8 , 0.001
Diastolic pressure (mm Hg) 42.6 6 10.5 27.4 6 7.9 , 0.001
Mean pressure (mm Hg) 60.5 6 11.5 44.7 6 8.7 , 0.001
Total pulmonary resistance (u) 21.1 6 9.3 14.8 6 7.0 0.002
Augmentation index (%) 225.1 6 26.9 27.4 6 15.2 , 0.001
Inflection time (ms) 210 6 49 97 6 20 , 0.001
CTPE 5 chronic pulmonary thromboembolism; PPH 5 primary pulmonary hyper-
tension.
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Figure 2 illustrates the pooled data representing pulmo-
nary hemodynamics. Systolic PA pressure was statistically
lower in CPTE than in PPH (77.1 6 14.8 and 97.2 6
16.6 mm Hg, respectively, p , 0.001) (Fig. 2). Diastolic PA
pressure was lower in CPTE than in PPH (27.4 6 7.9 and
42.6 6 10.5 mm Hg, respectively, p , 0.001) (Fig. 2).
Mean PA pressure was also significantly lower in CPTE
than in PPH (44.7 6 8.7 and 60.5 6 11.5 mm Hg,
respectively, p , 0.001) (Fig. 2). Despite these significant
differences in pulmonary hemodynamics, none of them were
remarkably capable of separating these two groups.
Figure 3 illustrates the comparison of the two reflection
indexes we proposed for differentiating between CPTE and
PPH. As shown in the left panel of Figure 3, the augmen-
tation index was significantly higher in CPTE than in PPH
(27.4 6 15.2 and 225.1 6 26.9, respectively, p , 0.001). It
separated the two groups reasonably well. The receiver
operating characteristic analysis indicated that the sensitivity
of augmentation index to differentiate CPTE from the
combined group of CPTE and PPH was 0.94, when the
cutoff value was chosen as 12% (5). The specificity for
excluding CPTE from the combined group of CPTE and
PPH was 0.94 (Fig. 4, left panel). The right panel of Figure
3 illustrates the inflection time of pulmonary arterial pres-
sure. Inflection time was significantly shorter in CPTE than
in PPH (97 6 20 and 210 6 49, respectively, p , 0.001).
Figure 2. Pulmonary hemodynamic variables in primary pulmonary hypertension (PPH) and in chronic pulmonary thromboembolism (CPTE). The closed
circles represent individual data.
Figure 3. Comparison of pulmonary artery reflection between primary pulmonary hypertension (PPH) and chronic pulmonary thromboembolism (CPTE).
The closed circles represent individual data.
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It separated the two groups reasonably well. The receiver
operating characteristic analysis indicated that sensitivity of
inflection time to differentiate CPTE from the combined
group of CPTE and PPH was 0.93 when the cutoff value
was chosen as 122 ms. The specificity for excluding CPTE
from the combined group of CPTE and PPH was 0.97 (Fig.
4, right panel).
DISCUSSION
We have shown that, although conventional variables of
pulmonary arterial pressure failed to differentiate between
CPTE and PPH, waveform analysis focusing on pulmonary
arterial reflection made it possible to differentiate CPTE
from PPH.
Clinical implications in differentially diagnosing CPTE
and PPH on the basis of the pulmonary arterial reflec-
tion. In clinical settings, the etiological diagnosis of pul-
monary hypertension remains a challenge. Noninvasive
techniques such as radioisotopic ventilation and perfusion
scanning and computed tomography have been extremely
useful in the differential diagnosis of pulmonary hyperten-
sion. They could, however, sometimes fail in the diagnosis
and necessitate study by angiography (6). Although pulmo-
nary angiography is a well-established technique in evalu-
ating PA disease, it could occasionally lead to sudden
cardiovascular collapse and even death (7). Thus, there are
obvious needs to develop tools to help in the etiological
diagnosis of severe pulmonary hypertension. We have dem-
onstrated in a previous study that the pulsatility analysis of
the pulmonary arterial pressure waveform provides useful
information in differentiating between CPTE and PPH (8).
As the measurement of PA pressure by a balloon-tipped
flow directed catheter is a relatively safe procedure as
compared with pulmonary angiography, the waveform anal-
ysis focusing on pulmonary arterial reflection added to
pulsatility analysis on the pulmonary arterial pressure wave-
form might help in differentiating between CPTE and
PPH.
Differing severity of pulmonary hypertension between
CPTE and PPH. In this investigation, although cardiac
output was similar, the PA pressure was significantly higher
in PPH than in CPTE. The severity of pulmonary hyper-
tension may influence on augmentation index or inflection
time. Therefore, we separately analyzed the diagnostic
significance of PA reflection in the subgroups with a similar
degree of pulmonary hypertension, whose mean PA pres-
sures was .40 mm Hg in CPTE and was ,60 mm Hg in
PPH (CPTE: n 5 23, PPH: n 5 16). Mean pressures and
total pulmonary resistance in the PA were similar for PPH
and CPTE (53.4 mm Hg 6 10.0 mm Hg vs. 48.4 mm
Hg 6 6.4 mm Hg, p 5 NS, 18.1 U 6 8.3 U vs. 16.3 U 6
7.4 U, p 5 NS). The results indicated that the augmenta-
tion index was markedly higher for CPTE than for PPH
(26.1% 6 15.0% and 228.5% 6 31.1%, respectively, p ,
0.001). Inflection time also separated the two groups
(95.3 6 19.8 and 216 6 55.0, respectively, p , 0.001).
These results were in line with those obtained from the total
group. Thus, the severity of pulmonary hypertension did not
appear to significantly modulate the basic characteristics of
the PA reflection of CPTE or PPH.
Study limitations. There are several limitations in the
study. We analyzed only a limited number of patients. To
generalize the results of this study, prospective studies
involving many patients are essential. Nevertheless, wave-
form analysis focusing on pulmonary arterial reflection in
CPTE would be expected to remain a useful, valid obser-
vation as it is based on the fundamental mechanical char-
acteristics of CPTE and PPH.
We used a fluid filled catheter to record pulmonary
arterial pressure. Although a high-fidelity catheter (tip)
manometer is preferred (9,10), the harmonic concept of the
PA waveform is so low that, when carefully filled, the
fluid-filled system can be used.
Conclusions. In conclusion, pulmonary arterial pressure
waveform analysis can offer an additional new approach in
the differential diagnosis that would help to discriminate
between CPTE and PPH.
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